跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ADEMPAS 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ADEMPAS 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
ADEMPAS 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Bayer Ag
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 9, 2023
Approval ID
afe80417f6a04454
Company
Bayer Ag
Type
Standard
Approval Details
Approval Id
afe80417f6a04454
Drug Cima Aemps Name
ADEMPAS 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
13907010IP
Holder Company Name
Bayer Ag
Marketing Company Name
Abacus Medicine A/S
Holder Company Detail Path
/organization/bayer-ag
Authorization Date
2023-03-09
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
2 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Bayer Ag
Company Detail Path
/organization/bayer-ag
Company Information
Pharmaceutical Company Name
BAYER AG
Name En
Bayer AG
Country Name
Germany
City Name
Leverkusen
Address
Leverkusen, North Rhine-Westphalia, Germany
Website
https://www.bayer.com
Active Ingredients
RIOCIGUAT
2 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 9, 2023
Approval ID
afe80417f6a04454
Type
Standard
Back to CIMA-AEMPS Approvals
